A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma

作者:Christian Beth; Alinari Lapo; Earl Christian Tyler; Wilding Emily; Quinion Carl; Lustberg Mark; Benson Don M Jr; Jones Jeffrey A; Byrd John C; Wegener William A; Goldenberg David M; Baiocchi Robert A; Blum Kristie A
来源:52nd Annual Meeting of the American-Society-of-Hematology (ASH), 2010-12-04 to 2010-12-07.
  • 出版日期2010-11-19